-
Mashup Score: 22IASLC Names New Chief Science Officer - ILCN.org (ILCN/WCLC) - 1 year(s) ago
Dr. Jennifer King brings expertise in molecular targets for cancer therapeutics as well as executive-level experience implementing strategic initiatives to the scientific affairs team.
Source: www.ilcn.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 22IASLC Names New Chief Science Officer - ILCN.org (ILCN/WCLC) - 1 year(s) ago
Dr. Jennifer King brings expertise in molecular targets for cancer therapeutics as well as executive-level experience implementing strategic initiatives to the scientific affairs team.
Source: www.ilcn.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0IASLC’s New 5-Year Strategic Plan Unveiled at Business Meeting - ILCN.org (ILCN/WCLC) - 2 year(s) ago
IASLC leaders also shared highlights from the association’s membership growth and financial report and officially welcomed President Dr. Paul Van Schil.
Source: www.ilcn.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Study Shows Exhaled Breath May Track Treatment Response in Mesothelioma - ILCN.org (ILCN/WCLC) - 2 year(s) ago
During WCLC 2023, researcher Dr. Kevin Lamote shared data that demonstrated VOCs in exhaled breath could be a useful biomarker.
Source: www.ilcn.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0First-line Nivolumab + Ipilimumab Superior to Chemotherapy in Metastatic NSCLC at 6 Years - ILCN.org (ILCN/WCLC) - 2 year(s) ago
Dr. Solange Peters presented new follow-up data from CheckMate 227 that show positive results regardless of PD-L1 expression.
Source: www.ilcn.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0KRYSTAL-1 Data Demonstrates Durable Adagrasib Response Against Mutated NSCLC - ILCN.org (ILCN/WCLC) - 2 year(s) ago
After more than 2 years, the median duration of response was 12.4 months and no new safety signals were seen, according to Dr. Shirish Gadgeel, who presented the results during WCLC 2023.
Source: www.ilcn.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Lectureship Award Winners Discuss Range of Issues in Thoracic Oncology During WCLC Plenary Session - ILCN.org (ILCN/WCLC) - 2 year(s) ago
Drs. Silvia Novello, Alan Sihoe, and D. Ross Camidge kicked off the session with forward-looking talks on tobacco control and smoking cessation, surgery, and medical oncology.
Source: www.ilcn.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Annual Award Recognizes Importance of Multidisciplinary Teams - ILCN.org (ILCN/WCLC) - 2 year(s) ago
The IASLC Cancer Care Team award highlights the teamwork required to provide the best possible patient care.
Source: www.ilcn.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Final Poster Networking Reception Tonight - ILCN.org (ILCN/WCLC) - 2 year(s) ago
Make time to visit the Exhibit Hall this evening to talk with poster presenters about their research.
Source: www.ilcn.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Plenary 4 Offers Early Look at 9th Edition of TNM Staging Classification for Thoracic Cancers - ILCN.org (ILCN/WCLC) - 2 year(s) ago
IASLC Staging and Prognostic Factors Committee Chair Dr. Hisao Asamura joins Drs. Valerie Rusch and Enrico Ruffini to review updates in lung cancer, mesothelioma, and thymic cancer.
Source: www.ilcn.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Meet the new @IASLC Chief Science Officer, Dr. Jennifer King @JenniferCKing in the #ILCN! https://t.co/t2VYCuyUl3